GMV 0.00% 3.9¢ g medical innovations holdings limited

Ann: Prizma Clinical Trials Completed for China Approval Process, page-8

  1. 732 Posts.
    lightbulb Created with Sketch. 598
    Ok so application in by April for NMPA, looks like on track for a June ish approval as flagged. Then its about converting MOUs which the company seems pretty confident of, but have been there before with no follow through.

    Things starting to progress though, so given this, the risk reward to owning at these levels looks pretty good


 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.